The purpose of this review is to examine the incidence and severity of refractive errors that occur post anti-VEGF injections for the treatment of ROP with consideration of confounders including birthweight, length of follow-up, cohort size, ethnicity, and severity of ROP. This evidence concerns the gene VEGFA and retinopathy of prematurity.